Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

pembrolizumab 223 Carboplatin 219 Cisplatin 206 Paclitaxel 182 Gemcitabine 149 Docetaxel 127 Capecitabine 115 Pemetrexed 102 Dexamethasone 102 Cyclophosphamide 102 Specimen Handling 99 Magnetic Resonance Spectroscopy 97 Oxaliplatin 96 Radiotherapy 95 Doxorubicin 92 Fluorouracil 88 Bevacizumab 84 Nivolumab 74 Leucovorin 73 Rituximab 71 Vincristine 68 durvalumab 66 Lenalidomide 64 Radiation 62 Etoposide 62 atezolizumab 61 Irinotecan 61 130-nm albumin-bound paclitaxel 58 Prednisone 57 Letrozole 55

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × darlin protein, Dictyostelium × 1 year × Clear all

NCT03180736 2025-12-19

EMN14

European Myeloma Network B.V.

Phase 3 Completed

304 enrolled 19 charts 1 FDA

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡